Huron Consulting Group Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HURN research report →
Range $213 – $220
Price Chart
About the company
Huron Consulting Group Inc. provides global professional services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial.
- CEO
- Mark Hussey
- IPO
- 2004
- Employees
- 9,248
- HQ
- Chicago, IL, US
Get TickerSpark's AI analysis on HURN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.72B
- P/E
- 24.31
- Fwd P/E
- 18.56
- PEG
- 2.21
- P/S
- 1.41
- P/B
- 6.76
- EV/EBITDA
- 14.59
- Div Yield
- 0.00%
- Gross Margin
- 30.94%
- Op Margin
- 11.24%
- Net Margin
- 6.10%
- ROE
- 26.67%
- ROIC
- 11.33%
Latest fiscal year · YoY change
- Revenue
- $1.70B+14.3%
- Gross Profit
- $508.79M+6.9%
- Op Income
- $199.30M
- Net Income
- $105.04M-9.9%
- EPS
- $6.02-7.7%
- OCF Growth
- -3.9%
- FCF Growth
- -5.0%
- 52W High
- $203.37
- 52W Low
- $84.88
- 50D MA
- $170.60
- 200D MA
- $138.27
- Beta
- 0.07
- RSI (14)
- 42
- Avg Volume
- 328.71K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Huron posted record third-quarter revenue growth and margin expansion, then raised EPS guidance while narrowing full-year revenue expectations on strong backlog and AI-driven demand.· November 3, 2026
- Q3 RBR hit a record $482.5 million, up 11.6% year over year, with growth across all three segments.
- Adjusted EBITDA was $77.3 million, or 16% of RBR, the highest quarterly adjusted EBITDA margin in 8 years.
- Adjusted EPS came in at $2.62, up 24.8% from $2.10 last year; reported EPS was $1.75 versus $1.71, with a $0.36 per-share hit from a noncash credit loss.
- Management narrowed 2026 RBR guidance to $1.855 billion-$1.885 billion and raised adjusted non-GAAP EPS guidance to $9.20-$9.40.
- Healthcare remained the main growth engine, while Commercial growth was slower organically but management expects investment and new industry hires to support stronger 2027 growth.
Third-quarter 2026 RBR was $482.5 million, up 11.6% from $432.4 million a year ago. Net income was $28.4 million, or $1.75 per diluted share, versus $30.4 million, or $1.71 per diluted share, last year; adjusted net income was $42.6 million, or $2.62 per diluted share, versus $37.4 million, or $2.10 per diluted share, up 24.8% year over year. Adjusted EBITDA was $77.3 million, or 16% of RBR, versus $67.4 million, or 15.6% a year ago. Healthcare RBR was $255.8 million, up 16.5%; Education RBR was $138 million, up 6.6%; Commercial RBR was $88.8 million, up 6.4%. Management narrowed full-year 2026 RBR guidance to $1.855 billion-$1.885 billion, affirmed adjusted EBITDA margin guidance of 14.5%-15%, and raised adjusted non-GAAP EPS guidance to $9.20-$9.40. Full-year free cash flow guidance was lowered to $150 million-$170 million, and the effective tax rate is now expected to be 27%-29%.
Mark Hussey said the quarter reflected broad-based organic growth, strong execution, and increasing demand tied to AI, especially in Digital, where more than 65% of bookings in the trailing six months had direct AI scope. He emphasized that the company’s backlog and pipeline support both the narrowed revenue guide and higher earnings outlook, and he pointed to 2027 as a year of continued growth, especially in Healthcare and from newly built Commercial capabilities. His tone was confident and upbeat, but he framed the company’s strategy as disciplined rather than aggressive.
John Kelly highlighted record revenue, strong margin performance, and a significant year-over-year jump in adjusted EPS, while noting the reported EPS comparison was affected by a $0.36 per-share noncash credit loss on a convertible debt investment. He also gave concrete cash flow and capital allocation details: Q3 operating cash flow was $57 million, free cash flow was $49.1 million, free cash flow guidance was lowered to $150 million-$170 million due to collection timing, and the leverage ratio improved to 2.6x from 2.8x. He said total debt was $815 million, cash was $25.6 million, net debt was $789.4 million, and the company repurchased $26.3 million of stock in the quarter, with $255.9 million still available for buybacks as of October 31.
Analysts focused on why Commercial growth was softer organically, and management said Consulting moderated after unusually strong restructuring work in the first half while Digital was roughly flat because some AI-related projects started later than expected. They also asked about Healthcare policy pressure, and Mark Hussey said 2027 should be harder for clients because Medicaid and ACA pressures will drive more unreimbursed care. On AI, management said clients are moving from hesitation to more proactive deployment, with use cases spanning governance, digital twins, data integration, ERP, and operational workflows across Healthcare, Education, and Commercial.
The call showed broad demand strength, with record revenue, the highest quarterly adjusted EBITDA margin in 8 years, and raised EPS guidance. Management repeatedly pointed to a strong backlog/pipeline, AI-related demand, and sustained Healthcare momentum, including recurring growth in Managed Services and a favorable 2027 setup.
Commercial’s organic growth was weaker than other segments, with Digital down 1% in the quarter and management saying some project starts lagged expectations. Free cash flow guidance came down because of working-capital timing in Healthcare performance-fee projects, and management acknowledged a higher tax rate and a reported EPS hit from the noncash credit loss.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.6%
- Shares Outstanding
- 15.78M
- Float Shares
- 15.41M
of shares held by institutions
252 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for HURN, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 1.68M | ▼ 98.18K |
| Blackrock, Inc. | 1.41M | ▲ 25.83K |
| Fiduciary Management Inc | 955.62K | ▼ 337.69K |
| Boston Partners | 811.64K | ▲ 9.04K |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas LLC | 729.06K | ▼ 23.16K |
| Vanguard Portfolio Management LLC | 710.19K | ▲ 1.45K |
| Vanguard Capital Management LLC | 701.52K | ▲ 8.51K |
| Franklin Templeton Inc | 671.14K | ▲ 37.11K |
| Dimensional Fund Advisors LP | 664.67K | ▼ 14.05K |
| Fmr LLC | 546.16K | ▲ 55.82K |
| Bloombergsen Inc. | 499.06K | ▲ 62.99K |
| Principal Financial Group Inc | 480.19K | ▼ 133.68K |
Held by 354 ETFs
Biggest fund positions in HURN by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 10, 26 | LOCKHART H EUGENE | other | 3,000 |
| Oct 2, 26 | Zumwalt Debra | sell | 82 |
| Aug 14, 26 | Zumwalt Debra | sell | 82 |
| Aug 11, 26 | SAWYER HUGH E III | sell | 2,000 |
| Jul 31, 26 | Featherstone Kyle | sell | 459 |
| Aug 1, 26 | Richards L Thomas | other | 593 |
| Jul 23, 26 | Richards L Thomas | other | 0 |
| Jul 29, 26 | Hussey C. Mark | sell | 4,972 |
| Jul 29, 26 | Hussey C. Mark | sell | 1,142 |
| Jul 29, 26 | Hussey C. Mark | sell | 2,507 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HURN coverage
Recent articles, reports, and earnings notes.
No research on HURN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HURN report →Huron Consulting Group Inc. $HURN Shares Newly Acquired by Ethic Inc.
defenseworld.net · Nov 16
3 Reasons Why Growth Investors Shouldn't Overlook Huron Consulting (HURN)
zacks.com · Nov 5
Wall Street Analysts See a 25.42% Upside in Huron Consulting (HURN): Can the Stock Really Move This High?
zacks.com · Nov 5
Are Business Services Stocks Lagging Huron Consulting Group (HURN) This Year?
zacks.com · Nov 5
Huron Consulting Group Inc. (HURN) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 3
Huron Consulting (HURN) Q3 Earnings and Revenues Beat Estimates
zacks.com · Nov 3
Huron Consulting Group Q3 Earnings Call Highlights
marketbeat.com · Nov 3
Compared to Estimates, Huron Consulting (HURN) Q3 Earnings: A Look at Key Metrics
zacks.com · Nov 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.